[Number needed to treat: a useful toolto evaluate the effectiveness of a treatment?]
Julia Gubler1, Laura Rossier1, Sophie Rotzetter1
1Service de médecine interne, Centre hospitalier de Bienne, 2501 Bienne.
Abstract:
This article reviews the clinical implications and limitations of the number needed to treat (NNT). Clinicians can quickly use this rather intuitive statistical value to assess the expected effectiveness of a treatment and explain it to patients. However, careful attention must be paid to the outcomes used in defining an NNT, as well as, the rate of the specific event in the population and the duration of observation. Conflicts of interest may also affect this easily manipulated statistical tool. Some often prescribed treatments have an NNT well above 20, implying an uncertain benefit for the patient, which emphasizes the need to carefully weigh the risk-benefit balance (NNT vs. NNH: number needed to harm) when prescribing. This review shows particularly low NNTs for anti-infectious agents compared to other drugs frequently used in medical practice.
More Related Videos
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Hazard Ratio
For example, in a clinical trial...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Therapeutic Index
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Comparing the Survival Analysis of Two or More Groups
